Drug Trial Radar · NCT03364491
Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean
Last checked: Nov 19, 2026Latest source record: Jun 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
11,000
Actual
Start
Mar 15, 2018
Primary completion
Jul 24, 2021
Study completion Oct 29, 2021
Sponsor
- Lead sponsor
- The George Washington University Biostatistics CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- First posted
- Dec 6, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A randomized placebo-controlled trial of 11,000 women to assess whether tranexamic acid as prophylaxis lowers the risk of postpartum hemorrhage in women undergoing a cesarean delivery.
Conditions
- Obstetrical Complications
- Hemorrhage
- Labor and Delivery
Interventions
Tranexamic AcidDrug
A single dose of Tranexamic Acid (1 gram) in normal saline for a total of 50cc, administered intravenously immediately following umbilical cord clamping (or as soon as possible afterward)
PlaceboDrug
50 cc normal saline administered intravenously immediately following umbilical cord clamping (or as soon as possible afterward)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Maternal Death or Transfusion of Packed Red Blood CellsTime frame: by hospital discharge or by 7 days postpartum, whichever is sooner
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama - Birmingham
Birmingham, Alabama
Northwestern University-Prentice Hospital
Chicago, Illinois
Columbia University
New York, New York
University of North Carolina - Chapel Hill
Chapel Hill, North Carolina
Case Western Reserve-MetroHealth
Cleveland, Ohio
Ohio State University Hospital
Columbus, Ohio
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
Magee Women's Hospital of UPMC
Pittsburgh, Pennsylvania
Brown University
Providence, Rhode Island
University of Texas Medical Branch
Galveston, Texas
University of Texas - Houston
Houston, Texas
University of Utah Medical Center
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.